Idorsia Ltd (OTCMKTS:IDRSF) Sees Significant Decrease in Short Interest

Idorsia Ltd (OTCMKTS:IDRSF) was the recipient of a significant drop in short interest in December. As of December 31st, there was short interest totalling 6,314,900 shares, a drop of 12.6% from the December 15th total of 7,229,000 shares. Based on an average trading volume of 12,600 shares, the days-to-cover ratio is presently 501.2 days.

Idorsia Price Performance

Shares of OTCMKTS:IDRSF opened at $0.91 on Friday. The firm’s 50 day moving average price is $0.98 and its 200 day moving average price is $1.84. Idorsia has a fifty-two week low of $0.70 and a fifty-two week high of $2.88.

Idorsia Company Profile

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.